Overall, these findings do not suggest that there is an additional increase in the hypoglycaemia risk attributed to physical activity with once-weekly icodec vs once-daily basal insulins in adults with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.